Literature DB >> 314681

Ten years' experience with mesocaval grafts.

J B Dowling.   

Abstract

A ten years' experience with this particular shunt has demonstrated that the patency rate, incidence of encephalopathy and of rebleeding and perioperative mortality have remained quite favorable when compared with other shunting procedures. Based upon a ten years' experience, we have no reservations in recommending it as the procedure of choice for patients with alcoholic or posthepatitic cirrhosis who are classified as A, B or C, according to Child's criteria.

Entities:  

Mesh:

Year:  1979        PMID: 314681

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  6 in total

1.  Budd-Chiari syndrome revisited: 38 years' experience with surgical portal decompression.

Authors:  Marshall J Orloff; Jon I Isenberg; Henry O Wheeler; Pat O Daily; Barbara Girard
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

2.  Eradication of esophageal varices with repeated injection sclerotherapy in inoperable patients.

Authors:  S Kitano; K Nagamine; T Iwanaga; K Beppu; N Koyanagi; Y Iso; K Sugimachi
Journal:  Gastroenterol Jpn       Date:  1986-02

3.  Fifteen years' experience with left gastric venous caval shunt for esophageal varices.

Authors:  K Inokuchi; K Beppu; N Koyanagi; K Nagamine; M Hashizume; T Iwanaga; K Sugimachi
Journal:  World J Surg       Date:  1984-10       Impact factor: 3.352

4.  Hepatic blood flow after canine portasystemic shunting.

Authors:  C H Shatney; J W Harmon; N M Rich
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

Review 5.  Bleeding varices: 2. Elective management.

Authors:  S S Hanna; W D Warren; J T Galambos; W J Millikan
Journal:  Can Med Assoc J       Date:  1981-01-01       Impact factor: 8.262

6.  Percutaneous control of a portacaval H-graft: description of a new device and its initial clinical application.

Authors:  R C Smith; A R Brown; P C Spencer; R W Gill; K A Griffiths; R J Lane; T S Reeve
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.